Kirkland Snags Roles on Private Equity Sale, BMS Pharma Pact
Kirkland is advising Bristol-Myers Squibb on a $482 million medicine licensing agreement and 3i Group in connection with with its $972 million sale of a plastics technology company.
"Kirkland & Ellis, which closed out 2012 by topping our list of most valuable firms and poaching a prominent M&A partner from Cravath, Swaine & Moore, is getting off to a good start on the transactional front this year with a pair of deals announced Tuesday."
To read the full text of this article, please click here.